| 1. |
Shiboski SC, Shiboski CH, Criswell L, et al. American college of Rheumatology classification criteria for Sjögren's syndrome:a data-driven, expert consensus approach in the Sjögren's international collaborative clinical Alliance cohort[J]. Arthritis Care Res (Hoboken), 2012, 64(4):475-487.
|
| 2. |
Ramos-Casals M, Anaya JM, García-Carrasco M, et al. Cutaneous vasculitis in primary Sjögren syndrome:classification and clinical significance of 52 patients[J]. Medicine (Baltimore), 2004, 83(2):96-106.
|
| 3. |
Fauchais AL, Magy L, Vidal E. Central and peripheral neurological complications of primary Sjögren's syndrome[J]. Presse Med, 2012, 41(9Pt2):e485-e493.
|
| 4. |
Morgen K, McFarland HF, Pillemer SR. Central nervous system disease in primary Sjogren's syndrome:the role of magnetic resonance imaging[J]. Semin Arthritis Rheum, 2004, 34(3):623-630.
|
| 5. |
赵媛, 郭燕军, 张拥波, 等.以亚急性脊髓损害为首发症状的原发性干燥综合征1例报道[J].中国神经免疫学和神经病学杂志, 2013, 20(2):143-144.
|
| 6. |
Lafitte C, Amoura Z, Cacoub P, et al. Neurological complications of primary Sjögren's syndrome[J]. J Neurol, 2001, 248(7):577-584.
|
| 7. |
舒荣, 杨文浩, 袁伟, 等.原发性干燥综合征的中枢神经系统病变[J].实用临床医药杂志, 2010, 14 (3):89-91.
|
| 8. |
Williams CS, Butler E, Román GC. Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide[J]. Arch Neurol, 2001, 58(5):815-819.
|
| 9. |
Alexander EL, Ranzenbach MR, Kumar AJ, et al. Anti-Ro(SS-A)autoantibodies in central nervous system disease associated with Sjögren's syndrome(CNS-SS):clinical, neuroimaging, and angiographic correlates[J]. Neurology, 1994, 44(5):899-908.
|
| 10. |
De Seze J, Delalande S, Fauchais AL, et al. Myelopathies secondary to Sjögren's syndrome:treatment with monthly intravenous cyclophosphamide associated with corticosteroids[J]. J Rheumatol, 2006, 33(4):709-711.
|
1/5
WeChat